$TXG
10x Genomics, Inc.
Nasdaq · Technology · Laboratory Analytical Instruments · Pleasanton, CA
TXG chart
What traders are saying about $TXG
Latest posts10x Genomics, Inc. news
- 10x Genomics Earnings Call Highlights Atera Momentum
TipRanks ·
- 10x Genomics Inc (TXG) Shares Fall 3.3% -- GF Value Says Still O
GuruFocus ·
- Fudan cancer center to use 10x Genomics platform in study
Investing.com ·
- Shanghai Precision Diagnostics and Fudan University Shanghai Cancer Center Launch Breast Cancer Biomarker Study Using 10x Genomics' Xenium Platform
PR Newswire ·
- A 500-patient study will look for clues to who responds to breast cancer treatment before surgery
Stock Titan ·
- TXG Q3 2026 deep dive: spatial platform launch and AI-driven demand shape outlook
Yahoo Finance ·
- JP Morgan maintains 10x Genomics at Neutral, lowers price target to $65 from $70
TradingView ·
- Is 10x Genomics (TXG) Cheap As It Lifts Full Year Guidance?
Simply Wall St ·
- 10x Genomics Raises 2026 Revenue Outlook, Targets 50 Atera Shipments
www.tokenpost.com ·
- 10x Genomics (TXG) Could Be 24% Undervalued After Raising Its 2026 Revenue Outlook
Yahoo Finance ·
- 10x Genomics (TXG) Stock Looks Overvalued After Its 289% Run
Simply Wall St ·
- 10x Genomics, Inc. Initial Statement of Beneficial Ownership
Stock Titan ·
10x Genomics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $642.8M | $610.8M | $618.7M | $516.4M |
| Net income | -$43.5M | -$182.6M | -$255.1M | -$166.0M |
| Diluted EPS | $-0.35 | $-1.52 | $-2.18 | $-1.46 |
| Total assets (year end) | $1.04B | $918.6M | $965.1M | $1.03B |
| Cash and equivalents (year end) | – | $344.1M | $359.3M | $219.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About 10x Genomics, Inc.
- Ticker
- TXG (Nasdaq)
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Pleasanton, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1770787
Frequently asked questions
What exchange is 10x Genomics, Inc. listed on?
10x Genomics, Inc. trades on the Nasdaq under the ticker symbol TXG.
What industry is 10x Genomics, Inc. in?
10x Genomics, Inc. is classified by the SEC under "Laboratory Analytical Instruments", part of the Technology sector on StockTweeting.
Where is 10x Genomics, Inc. headquartered?
10x Genomics, Inc.'s business address on file with the SEC is in Pleasanton, CA.
When does 10x Genomics, Inc.'s fiscal year end?
10x Genomics, Inc.'s fiscal year ends on December 31.
How much revenue did 10x Genomics, Inc. report?
10x Genomics, Inc. reported $642.8M in revenue for calendar year 2025, according to its SEC filings.